S&P 500   2,999.26 (+1.12%)
DOW   27,043.36 (+0.96%)
QQQ   193.48 (+1.25%)
AAPL   235.84 (-0.01%)
FB   189.70 (+3.50%)
MSFT   141.41 (+1.33%)
GOOGL   1,241.80 (+1.97%)
AMZN   1,759.68 (+1.34%)
NVDA   198.57 (+6.45%)
MU   46.37 (+3.37%)
BABA   176.43 (+3.08%)
GE   8.87 (+1.60%)
TSLA   258.55 (+0.62%)
T   37.91 (+1.17%)
ACB   3.79 (+7.98%)
NFLX   285.00 (-0.19%)
BAC   29.87 (+2.51%)
GILD   65.55 (+1.61%)
DIS   130.30 (+0.45%)
S&P 500   2,999.26 (+1.12%)
DOW   27,043.36 (+0.96%)
QQQ   193.48 (+1.25%)
AAPL   235.84 (-0.01%)
FB   189.70 (+3.50%)
MSFT   141.41 (+1.33%)
GOOGL   1,241.80 (+1.97%)
AMZN   1,759.68 (+1.34%)
NVDA   198.57 (+6.45%)
MU   46.37 (+3.37%)
BABA   176.43 (+3.08%)
GE   8.87 (+1.60%)
TSLA   258.55 (+0.62%)
T   37.91 (+1.17%)
ACB   3.79 (+7.98%)
NFLX   285.00 (-0.19%)
BAC   29.87 (+2.51%)
GILD   65.55 (+1.61%)
DIS   130.30 (+0.45%)
Log in

Trinity Biotech Stock Price, News & Analysis (NASDAQ:TRIB)

$0.92
+0.03 (+3.37 %)
(As of 10/15/2019 12:10 PM ET)
Today's Range
$0.90
Now: $0.92
$0.95
50-Day Range
$0.93
MA: $1.25
$1.45
52-Week Range
$0.89
Now: $0.92
$3.99
Volume851 shs
Average Volume95,965 shs
Market Capitalization$22.12 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease, sexually transmitted diseases, respiratory infections, epstein barr virus, and other viral pathogens; and products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a high risk of developing diabetes. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRIB
CUSIPN/A
Phone353-1276-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$97.04 million
Cash Flow$0.26 per share
Book Value$1.83 per share

Profitability

Net Income$-22,090,000.00

Miscellaneous

EmployeesN/A
Market Cap$22.12 million
Next Earnings Date10/22/2019 (Estimated)
OptionableOptionable

Receive TRIB News and Ratings via Email

Sign-up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter.


Trinity Biotech (NASDAQ:TRIB) Frequently Asked Questions

What is Trinity Biotech's stock symbol?

Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) posted its quarterly earnings data on Tuesday, August, 20th. The company reported ($0.19) EPS for the quarter, missing the Zacks' consensus estimate of $0.07 by $0.26. The company earned $22.50 million during the quarter. Trinity Biotech had a negative return on equity of 8.96% and a negative net margin of 30.92%. View Trinity Biotech's Earnings History.

When is Trinity Biotech's next earnings date?

Trinity Biotech is scheduled to release their next quarterly earnings announcement on Tuesday, October 22nd 2019. View Earnings Estimates for Trinity Biotech.

Has Trinity Biotech been receiving favorable news coverage?

News stories about TRIB stock have been trending somewhat positive this week, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Trinity Biotech earned a news impact score of 1.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Trinity Biotech.

Who are some of Trinity Biotech's key competitors?

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Netflix (NFLX), QUALCOMM (QCOM), Celgene (CELG), Gilead Sciences (GILD), Expedia Group (EXPE), Illumina (ILMN), Nightstar Therapeutics (NITE), Novavax (NVAX), Opko Health (OPK) and Supernus Pharmaceuticals (SUPN).

Who are Trinity Biotech's key executives?

Trinity Biotech's management team includes the folowing people:
  • Mr. Ronan O'Caoimh, Co-Founder, Chairman & CEO (Age 63)
  • Mr. Kevin Tansley, CFO, Company Sec. & Exec. Director (Age 48)
  • Dr. James Walsh, Exec. Director (Age 61)

How do I buy shares of Trinity Biotech?

Shares of TRIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Trinity Biotech's stock price today?

One share of TRIB stock can currently be purchased for approximately $0.92.

How big of a company is Trinity Biotech?

Trinity Biotech has a market capitalization of $22.12 million and generates $97.04 million in revenue each year. View Additional Information About Trinity Biotech.

What is Trinity Biotech's official website?

The official website for Trinity Biotech is http://www.trinitybiotech.com/.

How can I contact Trinity Biotech?

Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The company can be reached via phone at 353-1276-9800 or via email at [email protected]


MarketBeat Community Rating for Trinity Biotech (NASDAQ TRIB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  175 (Vote Outperform)
Underperform Votes:  228 (Vote Underperform)
Total Votes:  403
MarketBeat's community ratings are surveys of what our community members think about Trinity Biotech and other stocks. Vote "Outperform" if you believe TRIB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRIB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel